Find clinical trials for Pancreatic Cancer in Budapest, Budapest
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Budapest, Budapest, HUN:
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal, Pancreatic, or Colorectal Cancer...
Phase 3
Budapest, Hungary and 116 other locations
This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age...
Phase 1, Phase 2
Budapest, Hungary and 71 other locations
Phase I, first-in-human, open-label, multicenter, dose-escalation and dose expansion study with the aim of exploring safety, tolerability and prelimi...
Phase 1
Budapest, Hungary and 15 other locations
A Phase 1/2, open label, multi-center study to evaluate the safety, efficacy and tolerability of KY1044 as single agent and in combination with anti-...
Phase 1, Phase 2
Budapest, Hungary and 21 other locations
liposome injection in combination with other approved drugs used for cancer therapy, namely 5 fluorouracil/leucovorin (5FU/LV) plus oxalipla ...
Phase 3
Budapest, Hungary and 199 other locations
cell, pancreatic and biliary duct, endometrial, melanoma and urothelial tumors. This study contains two parts, single agent dose escalation...
Phase 1
Komárno, Slovakia and 40 other locations
Study to evaluate the efficacy, safety and tolerability of ponsegromab compared to placebo in patients with cancer, cachexia, and elevated G...
Phase 2
Budapest, Hungary and 123 other locations
To assess:efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification,...
Phase 2
Budapest, Hungary and 90 other locations
The aim of this study is to compare Onivyde manufactured at two different production sites in adult participants with advanced cancer in the...
Phase 1
Budapest, Hungary and 39 other locations
Primary Objective:For Cohort A, Cohort B, and Cohort C Part 2: To assess the antitumor activity of tusamitamab ravtansine in metastatic breast cancer...
Phase 2
Budapest, Hungary and 28 other locations
Clinical trials
Research sites
Resources
Legal